Translation of clinical trials into practice: A European population-based study of the use of thrombolysis for acute myocardial infarction

Lancet

Volumn 347, Issue 9010, 1996, Pages 1203-1207

  Woods, K L ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; DRUG USE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SYMPTOM; TIME;

EID: 0029926986     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90732-1     Document Type: Article

References (21)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
2. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248-54.
3. Weaver WD, Litwin PE, Martin JS, Hallstrom A. Use of thrombolytic therapy: how much impact have we made? J Am Coll Cardiol 1994; suppl: 245A.
4. Every NR, Larson EB, Litwin PE, et al. The association between onsite cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993; 329: 546-51.
5. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet 1993; 342: 891-94.
6. Norris RM, Roy S, Dixon GF. Clinical trials and clinical practice. Lancet 1993; 342: 1366.
7. LATE Study Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759-66.
8. Birkhead JS. Time delays in provision of thrombolytic treatment in six district hospitals. BMJ 1992; 305: 445-48.
9. Weston CFM, Penny WJ, Julian DG. Guidelines for the early management of patients with myocardial infarction. BMJ 1994; 308: 767-71.
10. Haigh RA, Castleden CM, Woods KL, et al. Management of myocardial infarction in the elderly: admission and outcome on a coronary care unit. Health Trends 1991; 23: 154-57.
11. Lear JT, Lawrence IG, Pohl JEF, Burden AC. Myocardial infarction and thrombolysis: a comparison of the Indian and European populations on a coronary care unit. J R Coll Phys 1994; 28: 143-47.
12. Adams J, Trent R, Rawles J. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. BMJ 1993; 307: 409-13.
13. Norris RM, Roy S, Dixon GF. What proportion of patients with acute myocardial infarction should receive thrombolytic therapy? Br Heart J 1994; 71: P40.
14. O'Donnell C, Eagle K, O'Gara P, Paul S. Eligibility for thrombolytic therapy is limited even with expanded criteria. J Am Coll Cardiol 1995; suppl: 206A.
15. Hamm CW. New serum markers for acute myocardial infarction. N Engl J Med 1994; 331: 607-08.
16. Elder AT, Fox KA. Thrombolytic treatment for elderly patients. BMJ 1992; 305: 846-47.
17. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993; 342: 1523-28.
18. Maggioni AP, Franzosi MG, Santoro E, et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med 1992; 327: 1-6.
19. Hannaford PC, Kay CR, Ferry S. Agism as explanation for sexism in provision of thrombolysis. BMJ 1994; 309: 573.
20. Ketley D, Woods KL. Agism and provision of thrombolysis. BMJ 1995; 310: 60-61.
21. Kee F. Gender bias in treatment for coronary artery disease. Q J Med 1995; 88: 587-96.